| Affiliation: | 1. Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan;2. The present address of Emi Mishiro‐Sato is the Department of Diabetic Complications, Research Institute, National Center for Global Health and Medicine, 1‐21‐1 Toyama, Shinjuku, Tokyo 162‐8655, Japan and Yoshinori Satomi is the Pharmaceutical Research Division, Discovery Research Center, Takeda Pharmaceutical Company Ltd., 2‐17‐85 Jusohonmachi, Yodogawa, Osaka 532‐8686, Japan.;3. Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki, Kiyotake, Miyazaki, Japan;4. Department of Anatomy, Showa University School of Medicine, Shinagawa, Tokyo, Japan;5. Frontier Science Research Center, University of Miyazaki, Kiyotake, Miyazaki, Japan;6. Saito Research Center, Peptide Institute, Inc., Ibaraki, Osaka, Japan;7. Institute for Protein Research, Osaka University, Suita, Osaka, Japan |
